Advancing Drug Discovery for Schizophrenia | The New York Academy of Sciences

This is an ebriefing from The New York Academy of Sciences from a recent conference, with full text of the key lectures.
 
Risk factorsSchizophrenia  
Kegg pathways  Schizophrenia 

No comments: